Now Administering First, Second and Booster Doses
Children 6 months to 15 of age must be accompanied by a parent or guardian.
Pfizer-BioNTech Vaccine
Available to eligible individuals age 6 months or older.
Moderna Vaccine
Available to those 6 months to 5 years of age and those age 18 or older.
Second Booster Doses
Adults ages 50 years and older who are not moderately or severely immunocompromised may choose to receive a second booster dose of the Pfizer-BioNTech or Moderna COVID-19 vaccine at least 4 months after the first booster dose.
Vaccine Clinic
Monday – Saturday
8:00 a.m. – 12:00 p.m.
Sunday
Closed
139 Summerplace Drive
West Columbia, SC 29169
First and Second Doses of COVID-19 Vaccine
The Pfizer-BioNTech vaccine is available to individuals age 6 months and older.
The dosage for the 6 months to 4 years age group is one-tenth of the adult dose. The dosage for the 5 to 11 age group is one-third of the adult dose. The dosage for 12 to 18 age group is the same as the adult dosage.
A second vaccine dose should be administered 21 days later for those ages 5 to 18. They will be considered fully vaccinated two weeks after the second dose of vaccine. A third dose should be administered to those age 6 months to 4 years at least 8 weeks later.
The Moderna COVID-19 vaccine is available to individuals age 6 months to 5 years and those age 18 and older.
A second vaccine dose should be administered 28 days later.
Booster Doses of COVID-19 Vaccine
The CDC and SC DHEC have approved booster doses of the Pfizer-BioNTech, Moderna and Janssen COVID-19 vaccines for the following eligibility categories:
Pfizer-BioNTech and Moderna
- Those age 5 years and older should receive a booster shot of Pfizer-BioNTech vaccine at least 5 months after their primary series.
- Those age 18 and older should receive a booster of the Moderna vaccine at least 5 months after their primary series.
Janssen (J&J)
- People aged 18 years and older should receive a booster shot. A booster shot of Pfizer-BioNTech or Moderna (mRNA COVID-19 vaccines) are preferred in most situations at least 2 months after their single dose primary series.
- Lexington Medical Center is NOT currently administering the Janssen vaccine at its community vaccine clinics. If inventory allows, we may add this option in the future.
Mix-and-Match Booster Guidance:
Individuals who are eligible for a booster dose may select which vaccine they receive. The eligible populations and dosing intervals for the heterologous (“mix and match”) booster dose are the same as those authorized for a booster dose of the vaccine used for primary vaccination. The booster dose (0.25mL) of the Moderna vaccine should be used whenever it is given as a booster. A different vaccine may not be used as part of the primary series.
Verification of Eligibility:
To expedite the registration process, individuals are asked to bring their COVID-19 vaccination card showing their first two doses of the Pfizer-BioNTech or Moderna vaccine or their single dose of the Janssen vaccine.
Dosage:
The booster dose is the same dosage as the first two dosages of the Pfizer-BioNTech and a half dose of the first two doses of the Moderna vaccine. The Janssen dose is the same as the initial single dose.
Timing:
The booster dose should be administered at least 6 months following the second dose of the Pfizer-BioNTech or Moderna vaccine. The booster dose for the Janssen vaccine should be administered at least 2 months following the single dose.
Third Dose of COVID-19 Vaccine for Immunocompromised Individuals
Lexington Medical Center also provides third doses of the Moderna and Pfizer COVID-19 vaccines for individuals who are immunocompromised and eligible, according to the SCDHEC guidelines below:
Eligibility for a third dose includes people with certain medical conditions or people receiving treatments associated with moderate to severe immune compromise:
- Active or recent treatment for solid tumor and hematologic malignancies.
- Other hematologic disorder which can cause an immunocompromised state.
- Receipt of solid-organ or recent hematopoietic stem cell transplants.
- Moderate or severe primary immunodeficiency (e.g., DiGeorge, Wiskott-Aldrich syndromes).
- Advanced or untreated HIV infection.
- Active treatment with high-dose corticosteroids (i.e., ≥20mg prednisone or equivalent per day), alkylating agents, antimetabolites, transplant-related immunosuppressive drugs, cancer chemotherapeutic agents classified as severely immunosuppressive, tumor-necrosis (TNF) blockers, and other biologic agents that are immunosuppressive or immunomodulatory.
Verification of Eligibility:
Individuals must self-attest their eligibility based on the criteria above by completing a form at our vaccine clinic or available for download here. Individuals must also bring proof of their initial two doses of vaccine, i.e. their vaccination card or other vaccination record.
Dosage:
The third dose is the same dosage as the first two dosages for both the Pfizer-BioNTech and Moderna vaccines. Individuals should receive their third dose from the same manufacturer as their primary vaccine series (first and second doses).
Age Criteria:
Immunocompromised individuals age 6 months and older are now approved to receive a third dose of the Pfizer-BioNTech vaccine. Immunocompromised individuals age 6 months to 5 years and age 18 and older may receive a third dose of the Moderna vaccine.
Timing:
The third dose of the Pfizer or Moderna vaccine should be administered at least 28 days following the second dose and should be the same mRNA vaccine as the primary series. Whenever possible, mRNA COVID-19 vaccination doses (including the primary series and an additional dose) should be given at least two weeks before initiation of immunosuppressive therapies.
Schedule your appointment below for first, second or third dose. Appointments are not required and walk ins will be accepted.